International & Interactive Mixed Reality Art is a Showing AV Pros the Value of “Digital Plasticity”

The design of new art mediums in Web3 is as much a social coordination as it is a technological cooperation. Designers, engineers, and visionaries are now able to collaborate to create mixed reality art, working in augmented mixed reality frameworks so as to define and refine the architecture of the metaverse.

By using digital plasticity, the analog and traditional concept of a group of people developing a professional or creative idea is re-imagined, evolving beyond the traditional limitations of place, space, and time.   

Mango Dogwood, the creative director of Ethereum-based NFT protocol Charged Particles and a hybrid real-world and metaverse event planner, believes the key to combining emergent technologies in virtual reality, augmented reality, and mixed reality is to produce uniquely novel experiences that spur interactive international participation, using real-time adaptive feedback systems that stimulate our common curiosity, creativity, and humanity. AV experience designers could draw a thing or two from this approach to mixed reality art, especially as the medium for these experiences increasingly becomes hybridized.

Mango’s Thoughts

“Some of the things that come to mind immediately are like a 3D sculpture painting within VR where you can be like literally manifesting physical sculptures from a wand in your immediate 3D space in this way that wouldn’t be possible in the physical world.

Maybe with some sort of slow 3D printing type thing, but really being able to like really create within these new formats and these new mediums and in a way that you could be like collaboratively creating with people from around the world all at the same time.

So someone at the air hanger in Denver can be situated with a VR headset making a live sculpture that then you could maybe see through the phone at the physical party. But then someone in Nigeria and someone in China and someone in India are all adding to that same growing art piece in this way that it’s a completely new way of connecting socially and collaborating artistically with people.

So I think like lots more of these sorts of experiences…for me, the live art creation is some of the most exciting stuff where you can be working with people directly from across the world in these new formats.”

Follow us on social media for the latest updates in B2B!

Image

Latest

Doable
Rethinking Leadership: Why “Doable” Might Be the Most Powerful Strategy in Education Today
April 3, 2026

At a time when educator burnout is rising and schools across the U.S. are facing ongoing teacher shortages, leaders are being forced to rethink what sustainable success actually looks like. Research shows that teacher attrition is closely tied to working conditions, job-related stress, and workload demands. As districts push for innovation, data-driven instruction, and…

Read More
Casey Brown
From Poverty to Pricing Power | Why Great Companies Undercharge
April 2, 2026

Casey Brown didn’t grow up thinking she would become an entrepreneur. She grew up in a blue-collar family where money was always tight — close enough to the edge that the fear of poverty shaped many of her early decisions. That fear led her into engineering, into corporate America, and eventually into a moment…

Read More
Nightingales Summit: Empowering the Next Generation of Nigerian Nurses
Nightingales Summit: Empowering the Next Generation of Nigerian Nurses
April 2, 2026

In this episode of Care Anywhere, host Lea Sims sits down with Nigerian nurse entrepreneur and advocate Obafemi Arowosegbe to discuss leadership, mentorship, and the future of nursing in Africa. While still a nursing student, Obafemi founded the Nightingale Summit, a growing conference designed to empower nursing students and early-career nurses with leadership skills,…

Read More
Oncology
From Denial to Access: Rethinking Oncology Care Through AI, Clinical Trials, and Patient-Centered Innovation
April 1, 2026

The rapid expansion of precision medicine, biologics, and targeted cancer therapies is transforming oncology—but it’s also overwhelming a system not built to keep pace. In the U.S., cancer drugs now account for some of the highest-cost treatments in healthcare, and with that has come a surge in prior authorization requirements and denials. Studies suggest physicians…

Read More